Status:
COMPLETED
Use of Epidurals Intraoperatively for Patients Undergoing Pancreas Resection
Lead Sponsor:
Memorial Sloan Kettering Cancer Center
Conditions:
Pancreatic Cancer
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to see if there is a difference in complications in patients who have an epidural started earlier (during their surgery) and used as part of the anesthetic in addition to ...
Eligibility Criteria
Inclusion
- Adult patients ≥ 18 years of age who can provide informed consent
- Scheduled for pancreaticoduodenectomy
Exclusion
- Pregnancy
- History of documented anaphylaxis or contraindication to any of the study medications
- Significant cognitive impairment or documented psychologic impairment
- Contraindication to epidural per Pain Service guidelines
- Use of a sustained release opioid medication such as long-acting morphine, fentanyl patches, methadone, and buprenorphine within the last 3 months
- Post randomization exclusion will occur if the patient is found to have unresectable disease at laparotomy and therefore will not have the potential for the same postoperative complications.
Key Trial Info
Start Date :
January 30 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 10 2024
Estimated Enrollment :
133 Patients enrolled
Trial Details
Trial ID
NCT03434678
Start Date
January 30 2018
End Date
July 10 2024
Last Update
July 30 2025
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Memorial Sloan Kettering Basking Ridge (Consent only)
Basking Ridge, New Jersey, United States, 07920
2
Memorial Sloan Kettering Commack (Consent only)
Commack, New York, United States, 11725
3
Memorial Sloan Kettering Cancer Center
New York, New York, United States, 10065